Google TrendROB LOWE (1000+) — Daily Wire's 'Confession': Details Revealed For James Franco, Rob Lowe Film
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Safety and efficacy of th" (30 stories)

Top Headline Story

NovaBridge Biosciences Announces Expanded Givastomig Safety and Efficacy Data to be Presented at the European Society for Medical Oncology 2026
Lead StoryGlobeNewswirescience
5d ago

NovaBridge Biosciences Announces Expanded Givastomig Safety and Efficacy Data to be Presented at the European Society for Medical Oncology 2026

<a href="https://news.google.com/rss/articles/CBMiuwJBVV95cUxQalg1MXc0OU9nU0RIQXg5RHpRS3dOVFViVkRnX3JON1V0M3ZQTXZmNUhkVTFpcnBYRnFKbm5kT1ljRDZQM3VKTFFRTm9lTkNaRTZ1NW9vRFMza1M4aGJ3YnA5dFJmcDlqNHgzVkJzODZRY1J6Wjl1ODFiVkFTMzVRTnhBVExOeVZ1dTFsMUc3V0I3WllESml5dHc2QUptV3p5NUt4V2dpME1TcklNRzIycmh6aTNZVFd6dDNfSkQybXZQS0VsbFZPcVkwdXhIQVBGbWhEb29Tb0pjMkJLbDJyRDlmcGs5OHpMemRMaUZDa190UzMxV2ZkMGlxeDMxTDYyY3M3ZFUyTGtHSC1SaXRfRDhTTXN6bTFGR3h0c2Z1a0dxQUhGU1JzTVJvZTNLa2toQlk0SENWV0p6Mms?oc=5" target="_blank">NovaBridge Biosciences Announces Expanded Givastomig Safety and Efficacy Data to be Presented at the European Society for Medical Oncology 2026</a>  <font color="#6f6f6f">GlobeNewswire</font>

Real-time search volume
1000+24m ago

rob lowe

Daily Wire's 'Confession': Details Revealed For James Franco, Rob Lowe Film

500+24m ago

tanner hudson

Bengals tight end Tanner Hudson out for season with torn pec

1000+34m ago

payton pritchard

Celtics to extend guard Payton Pritchard on 2-year, $44.2M deal

500+34m ago

huevo

Ministerio de Agricultura realiza primera Mesa Técnica del Huevo para abordar desafíos del sector

Search Results for "Safety and efficacy of th"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Safety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial
The Lancetgeneral

Safety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxQQ3o2RmRxZ3N6eXVZeWpLNmFNNF9uZ01QZ1pOTGhQZGxUMk1KOTVrbnRpSk4wVzliWll6dnZLck5QWGdTVlZ6VHVJNFNRelRXQVh3VWpUb2dJYlIxck9rMkh5aFB0djUyRXh5eFNnNWloV2g1TlNNWkFWRXJualc4MzRWQy1FbF9rTkZn?oc=5" target="_blank">Safety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial</a>  <font color="#6f6f6f">The Lancet</font>

IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
PR Newswiregeneral

IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY

<a href="https://news.google.com/rss/articles/CBMi4gFBVV95cUxPSGVJeHJXZ21wSjVSSnJMTV9DcEZHUm8tQUhwQUUzeTZGLVVOQnIxZWdYdEJZd2xOVUtGdm85M2hld2xDZTJSb0VtajV4U1pkZHNxZV90UVNQM1YtMzJLVUxXLS1JYV96a0xNWkQ0NmxwTnBNT1kyNTlLU2Q2cnZHMlhtaENndEIxQWdqeERoamZUOXdqVDJDS0dIdDVObTkxUHJiNmstMzVSWEJaTVN2Q1ZQZUxNUFRTNmdwLWw2Vjh1X0E5SDZRTjU4eWRFUkxxOV9IVUN1bkJwQl9OclJjR3Bn?oc=5" target="_blank">IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY</a>  <font color="#6f6f6f">PR Newswire</font>

Efficacy and safety of albumin combined with endovascular therapy in the treatment of patients with acute ischemic stroke: a randomized clinical trial
Naturegeneral

Efficacy and safety of albumin combined with endovascular therapy in the treatment of patients with acute ischemic stroke: a randomized clinical trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9KeHFEMkJHWnhYU2hVcnAtaElVNnlLdzFBZUNIR3dCazNicDhlYzBzbzh2SkVSMThrTGNuazY3WW56aDJLRTlpdTh5TjNDSDhINEduajU2LXA3RHN3OTFR?oc=5" target="_blank">Efficacy and safety of albumin combined with endovascular therapy in the treatment of patients with acute ischemic stroke: a randomized clinical trial</a>  <font color="#6f6f6f">Nature</font>

Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults
NEJMgeneral

Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTFBXODNYSkU3VTc4ZGFDS0lxdzZwRFU1a2o4MlhkR3d4NktUQ0pmbVYwWlRVbWVNVzVlemxWOVhvd2cxNExNRWUyNV9TZ3JLVE9hWmVOMmRIZVozNGN0NURVcw?oc=5" target="_blank">Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults</a>  <font color="#6f6f6f">NEJM</font>

LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer’s Disease Presented at the Alzheimer’s Association International Conference® (AAIC®) 2026
Biogentech

LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer’s Disease Presented at the Alzheimer’s Association International Conference® (AAIC®) 2026

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxOV3lQcmlldnhPX1N4NWpJZ21rT0lXVGdNRjZzUVVFX3pGaS1fem4xRG1CQ1JYaHFSNzhKTW1hUEZyYjd3VVRzcWlzSW4zUy1EUllLVzRYOXltZElUNDhadWVKekJZWXFnQVZ5VTZhN2JwbU5nNG1aRExYR3NjSG0wYkJSZVpnRnRKWHpFdVcyZF9UUG5DakFVbWlnZWJZeUZLdG9hSmtVQnVhQ3I0dUhZUWtEcmRkNi01QnpKalBR?oc=5" target="_blank">LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer’s Disease Presented at the Alzheimer’s Association International Conference® (AAIC®) 2026</a>  <font color="#6f6f6f">Biogen</font>

Atsena Presents Positive Preliminary Safety and Efficacy
GlobeNewswiregeneral

Atsena Presents Positive Preliminary Safety and Efficacy

<a href="https://news.google.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?oc=5" target="_blank">Atsena Presents Positive Preliminary Safety and Efficacy</a>  <font color="#6f6f6f">GlobeNewswire</font>

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective
The Lancetscience

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxPN012M2dKdFJmeFM5SjczUldZRWE3ZUNXZUdSNURKMGJveHUwb3Z0TWFJcW9RazJLNUFOZnBEWXZUdWNXWGdGR0ZrV2FSdXZ1VC1tOVNfTmhfTDRaVnNCNnFXdUxaVEVWV3JGT3lyTzJTSXhWbmllaHJHdnhzNHV6TmdOUG13U1dkMm1B?oc=5" target="_blank">Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective</a>  <font color="#6f6f6f">The Lancet</font>

Efficacy and safety of pilocarpine for the treatment of presbyopia: a systematic review and meta‑analysis of randomized controlled trials
Naturegeneral

Efficacy and safety of pilocarpine for the treatment of presbyopia: a systematic review and meta‑analysis of randomized controlled trials

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5vM1BYREVKSl9KWEdQcjRWMVFMMTh6NTI0MWQtcGs4VGNROUlZRGF5eXF5ZFlvaDQ5UDZWanZnU042ZTBPQVVKUlZ0YlJUbXYwYW1nWjJSa3dPVHVRQVVj?oc=5" target="_blank">Efficacy and safety of pilocarpine for the treatment of presbyopia: a systematic review and meta‑analysis of randomized controlled trials</a>  <font color="#6f6f6f">Nature</font>

Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus
NEJMgeneral

Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE5JZG9uRGx1RDNwaGdjdzU2NkY5eUlzaWwwRWJpc1QyclVBc0V3cVpPQkpoOUw5VExqNzNoZlZCZ2NJdUtiWndDN2dwZG5saVVDQUgwdU5MQzdETGRqa2stbQ?oc=5" target="_blank">Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus</a>  <font color="#6f6f6f">NEJM</font>

Teva Presents New Efficacy and Safety Data with Ecopipam,
GlobeNewswiregeneral

Teva Presents New Efficacy and Safety Data with Ecopipam,

<a href="https://news.google.com/rss/articles/CBMiqwJBVV95cUxNSFZXMk5iUFotTjdhc2x0cTB0WGZaZVBLMDlHR09iTm9ZS2gxazRzSHFvd2M5bVRJZHBXbXQ0RVV6ejEtUHB6X2RaQ0dEZWx4UVlqSnpoN2Z5am5zS1lvMDF2VmRwMzRkVFNVbzNVbjlxSGdnbkFWanFKWFJRMFotNlRfaDNmUUV2emJRVUM1XzVsaXhPN0xobllmMGZvcFA4dFAzR2ZaRFo3OG1XZDlmRVNKcml6VWg2QWlZRjVqZVBxaWZHZDVFeEtZeGQ3YTN4ZUtnSGpxaURpNmdyVFh6S1FYbUM1dHJYWXhTYndQa1c2Mnp6RE9zbFpNa1ZuSXBVaWRyWWFHS2NMRnRVNzRlU3FNdGM4Z1pPTFd6dW4yS19qaXhRVlUzd2prNA?oc=5" target="_blank">Teva Presents New Efficacy and Safety Data with Ecopipam,</a>  <font color="#6f6f6f">GlobeNewswire</font>

Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1
Naturegeneral

Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE80emxRdmUtSGV2ckpON2FPSkRMUjJwSmZWSndOUE9UU3c4cy1ERGhEVmpnSHVsdmtyUEtpZ21HLW11TXBiSUcxeHJzQnhNOWhucHVWMDQ1ZEoxUXF5MENB?oc=5" target="_blank">Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1</a>  <font color="#6f6f6f">Nature</font>

Safety and efficacy of the monoclonal antibody L9LS for malaria prevention in children exposed to perennial malaria transmission in Kenya: a randomised, double-blind, placebo-controlled, phase 2 trial
The Lancetgeneral

Safety and efficacy of the monoclonal antibody L9LS for malaria prevention in children exposed to perennial malaria transmission in Kenya: a randomised, double-blind, placebo-controlled, phase 2 trial

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxNOFh1WVhlZWczdno2Z2YxQkZwcUdNeWZvYWlSVHpVdXVVUWpMYUltYVMyQk1tcEhTQ0JrcTFiRWlpcGRvVENSVnlqNHZma1R5R2haZWdsLUMzaGxXT3BqRlVzdFB6WDdMMTZwTUFtMHZSM1hiVmd4WG5YMHNQTlFELWl2cGVTLU9wYnZF?oc=5" target="_blank">Safety and efficacy of the monoclonal antibody L9LS for malaria prevention in children exposed to perennial malaria transmission in Kenya: a randomised, double-blind, placebo-controlled, phase 2 trial</a>  <font color="#6f6f6f">The Lancet</font>

Vaccination in individuals with Down syndrome: immune vulnerability, safety, efficacy and opportunities | npj Vaccines
Natureworld

Vaccination in individuals with Down syndrome: immune vulnerability, safety, efficacy and opportunities | npj Vaccines

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9TdVZWM25CMTNzeDlOSnlnVmdMWU9zd2M4enBfeWUyc3ZSTDVIT0k0SEdoVDMyME03WWJtU3U2X1BQdFE5V3ZHWE5mSUZtTlQtTm5NbHB0X2ZXNEJsT21z?oc=5" target="_blank">Vaccination in individuals with Down syndrome: immune vulnerability, safety, efficacy and opportunities | npj Vaccines</a>  <font color="#6f6f6f">Nature</font>

Safety, pharmacokinetics, and antimalarial efficacy of single-dose cabamiquine–pyronaridine combination therapy for the treatment of adults and adolescents with acute uncomplicated Plasmodium falciparum malaria (CAPTURE 1): a prospective, multicentre,
The Lancetworld

Safety, pharmacokinetics, and antimalarial efficacy of single-dose cabamiquine–pyronaridine combination therapy for the treatment of adults and adolescents with acute uncomplicated Plasmodium falciparum malaria (CAPTURE 1): a prospective, multicentre,

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxPeE12VGhmbjQ2cUFaZmMwb1UwekNZek5HU3E3cUlTOERCQl9uOWF6U0ROYzJMWVZzYkIwM0JKMVpJMmp2OWpyWmZ1WVdlTkpkZ0NGVGpVVTlkY0NKanFoWm9maG1wUWFRYkJEMEszbllOTE5zZjF1RWFxeDV5RXVKck9LRWlPQlRwS3ZN?oc=5" target="_blank">Safety, pharmacokinetics, and antimalarial efficacy of single-dose cabamiquine–pyronaridine combination therapy for the treatment of adults and adolescents with acute uncomplicated Plasmodium falciparum malaria (CAPTURE 1): a prospective, multicentre,</a>  <font color="#6f6f6f">The Lancet</font>

Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial
Naturegeneral

Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE4wQnlIS2dPU2NJbXVzdENxelQ2MGNac3pCR2VrUE5TMDVITzZ3amJUaHlNODBXYldHSmFXeEEyQWtKMmRGSEpkaEk3aVFNVHZOUDZseEZGd191R1ZQbTlV?oc=5" target="_blank">Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial</a>  <font color="#6f6f6f">Nature</font>

We’re going bananas! The effectiveness and safety of banana puree as an intervention for improving oral feeding in a level IV NICU
Naturegeneral

We’re going bananas! The effectiveness and safety of banana puree as an intervention for improving oral feeding in a level IV NICU

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9xckhid09qQm9ienpiZmJVZTVWdG52LV9FLVFnc3Q1amJyNGUxbFJnM0FPQ0JiRF9vWjN1NC0wMWRxbjQ2QnVXQTMtQWZFeTg1U0ZCT2cxcnkyYkY0elRv?oc=5" target="_blank">We’re going bananas! The effectiveness and safety of banana puree as an intervention for improving oral feeding in a level IV NICU</a>  <font color="#6f6f6f">Nature</font>

Impact of venetoclax trough levels on safety and efficacy in the treatment of acute myeloid leukemia
Naturegeneral

Impact of venetoclax trough levels on safety and efficacy in the treatment of acute myeloid leukemia

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBvWmxSbEl0OV9fYk4yTnpLUGpidHJlVFNTeXZ3TXJRVm03YmE1YWdxVlV4eHRtc3RYQ1QzUktncEstOU1kRm5Cci1ONTllbHZHSFlSZG1YN1hKeE5VZlNJ?oc=5" target="_blank">Impact of venetoclax trough levels on safety and efficacy in the treatment of acute myeloid leukemia</a>  <font color="#6f6f6f">Nature</font>

Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination
Naturegeneral

Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBqVFF6UFd4RjAyV3BCQVhxX0t3SWtMTlJMSDNiN0lWZ3NUYTJlY21lUnJLN296QUpnWENFQmtySnBKc01Uc1dDSmFkX2xBU0NSZGswOHpPV0tFQnFlX1Fn?oc=5" target="_blank">Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination</a>  <font color="#6f6f6f">Nature</font>

Efficacy and safety of e.p.t.q. hyaluronic acid fillers in the context of aesthetic facial rejuvenation or beautification: a post-market clinical follow-up study
Naturemarkets

Efficacy and safety of e.p.t.q. hyaluronic acid fillers in the context of aesthetic facial rejuvenation or beautification: a post-market clinical follow-up study

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBxS24ybHljMVdnenY0MWdYLVROSVV4QmpxdHdmMndhVW5GNlY2ZGp3MGNjMlZ2dW9lRkFpRGw1U1NLNi1NaXBNc19vdXE1blEtVEhFcW4xZE14WXY4eC1R?oc=5" target="_blank">Efficacy and safety of e.p.t.q. hyaluronic acid fillers in the context of aesthetic facial rejuvenation or beautification: a post-market clinical follow-up study</a>  <font color="#6f6f6f">Nature</font>

Safety and Efficacy of the Stag Beetle Knife for the Management of Zenker’s Diverticulum: An Updated Systematic Review and Meta-Analysis
Cureusgeneral

Safety and Efficacy of the Stag Beetle Knife for the Management of Zenker’s Diverticulum: An Updated Systematic Review and Meta-Analysis

<a href="https://news.google.com/rss/articles/CBMigwJBVV95cUxNOGo3R2ZGLUE2T0lMN3E2UDIzTmp3ZE1qYkRBT2FSNnVodGxDT0VhWjRHQklLT3NGcTdya0Q4bk5Lek52eFdCU2dYT19RdkVVVTU4ek5TTWJiSnh6VGJwRjRZRXdhQ1lzMjQ5WWhzRXBhRDM0bDJkbDBHUUhPdXN0eWQ4Q1RfRUx1Y0Mxb04xSGFfd3ExOTRKd3VQeWlCRExyYWZkYUZwZURUYk43a1BDV01XZmFRODl4blJscUdxU1lVN1dsMlFwVlhXTWJJM09jREh1SXdCamZfallocGJucVZYSHdjYlFMYW1fUk1ZaUw4Z2t3aTVmdXJMNzJ3M2g2YXIw?oc=5" target="_blank">Safety and Efficacy of the Stag Beetle Knife for the Management of Zenker’s Diverticulum: An Updated Systematic Review and Meta-Analysis</a>  <font color="#6f6f6f">Cureus</font>

Safety and Efficacy of Intranasal Esketamine for Major Depressive Disorder and Treatment-Resistant Depression
Psychiatric Timesscience

Safety and Efficacy of Intranasal Esketamine for Major Depressive Disorder and Treatment-Resistant Depression

<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxQOXFNUUN2ckdBTmZZMXlLdFZCdlVtVFhIRXJ6eXpjZU5Wd3JlT09hYnNvZkwzcVdGalRfNkY1aEhHMkpfRkpOa01HZWlUVXBTMVJoLXVCYmQ2RXZYdXY0R0drLW9IUEd6b01BZzVDRzREZmxLME9JLXBubUltQnVGVjg4aThENnlUaUkwaGtqYUtvYzFGN1pHUFcwVFVZN2N2TUl2RDFieHpWcnFOMk4zNVV0dWU0NUZmYmZvMkJCQ2hXZ0tnOUFqWV81Vk9pZmF0YXdfUjl4aWhEeExGaTJmbw?oc=5" target="_blank">Safety and Efficacy of Intranasal Esketamine for Major Depressive Disorder and Treatment-Resistant Depression</a>  <font color="#6f6f6f">Psychiatric Times</font>

An open-label study to evaluate safety, efficacy, and acceptability of PentaSure Fiber in the management of functional constipation in children
Natureworld

An open-label study to evaluate safety, efficacy, and acceptability of PentaSure Fiber in the management of functional constipation in children

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5SR05LLUtJdDk4RDJFcXVvd1VMb3RNQ2NyMWw5S0ppNjZLd3ktRUxGZUNzckYtTkRxUFZPQm1KYXExNi02bFJuaW9DZUoyS3lWcjlGUGN2d3oxTVlaVjBn?oc=5" target="_blank">An open-label study to evaluate safety, efficacy, and acceptability of PentaSure Fiber in the management of functional constipation in children</a>  <font color="#6f6f6f">Nature</font>

Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials
The Lancetgeneral

Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxNbjBaZk1OSS1ZbzBLbjlyMGRMS2daVmViQ0VqUkZQUUdvQ19GSjNJNGJEeXVKU2hWbTloZWFlRkMySUItaGxmOUMtWXJLeXAyZVQxcEZ3S1ViNUFCQkY2Zm5IY1pPS2dGS0ZjcEs4dXJ3dEFSRUZ3NmRtQ1NOZEZWTk9MR3RiTnZEVmYw?oc=5" target="_blank">Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials</a>  <font color="#6f6f6f">The Lancet</font>

Safety and Efficacy of Maintenance Treatment With Aripiprazole Once-Monthly in Black/African American Adults Diagnosed With Bipolar I Disorder: Post Hoc Analysis of a 52-Week, Open-Label Study
Psychiatrist.comtech

Safety and Efficacy of Maintenance Treatment With Aripiprazole Once-Monthly in Black/African American Adults Diagnosed With Bipolar I Disorder: Post Hoc Analysis of a 52-Week, Open-Label Study

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOaWVUUlpkeU1ZY2lCcFdGcHQwbHJCc045LUxka0tlRWZCMElHUEZWR215b0pkaG9xaWxEeERreUhMZU5VTmh4TDM1djk4V1RZYmJ0a3pmeG9rbklqRFF3NW9hbFFzMk9PUU0tYkdqRGluY2pDOWlXRDBWRXpOMjdIWXF1MlAyMnR1QUF3OHJzZjNfYmpqSk45czZGSElfTVgteURveXdWcDNqQlpObjBrTUhweGtBTFJZZHUw?oc=5" target="_blank">Safety and Efficacy of Maintenance Treatment With Aripiprazole Once-Monthly in Black/African American Adults Diagnosed With Bipolar I Disorder: Post Hoc Analysis of a 52-Week, Open-Label Study</a>  <font color="#6f6f6f">Psychiatrist.com</font>

Efficacy, immunogenicity, and safety of the 9-valent human papillomavirus vaccine in males aged 16–26 years in Japan: a randomised, double-blind, placebo-controlled trial
The Lancetworld

Efficacy, immunogenicity, and safety of the 9-valent human papillomavirus vaccine in males aged 16–26 years in Japan: a randomised, double-blind, placebo-controlled trial

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxQMXFBck0tSjBYLVdrVVRLQmdvM3VELUJhVWdBNjlSUE1kTGlOZFFVeXA0eGRhMmJPamdGUWRBMVFIVG8zbUItZlBoSFJ4Q3ZGempNQ3RQV0pGaXFLVlRiWHpCZHlzZUExQklZQ25BRU14ZDVrVXk0MF91VURzWUNQaW9VcVZxcU11RU13?oc=5" target="_blank">Efficacy, immunogenicity, and safety of the 9-valent human papillomavirus vaccine in males aged 16–26 years in Japan: a randomised, double-blind, placebo-controlled trial</a>  <font color="#6f6f6f">The Lancet</font>

Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study
The Lancetgeneral

Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxORWdaYWJpMjE2YkFVNDFiNko0bFZxaFZ2Vks2ZU9qT3Z1OGVSLXlVOVZ6cFlFMVdIaVY2cDQ4SmlZYnZkOHFfdUxaOEpaMFdsZnh0YW1mLTNQdGJCRFZNQnZFZ1hkUmFGVExnUV9ybGhycHctUkJXcDhadnAwOEV4Q250ZFdXa204d2Rv?oc=5" target="_blank">Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study</a>  <font color="#6f6f6f">The Lancet</font>

Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials
The Lancetscience

Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxQM2NkcUsxcE9ieHNkeDJiTEdxZ0g3SXlvZFo2bzlNS3F0UDNwUE1mR3pJT2k0MmdwOFdpdHY1ak94TUtFVzQ0VmlXQ3hPNDFKZEhyT1BTUnphcFhkMmVGZWNDY3VpR3YwZl9zakxfamJBTGJmOUVfSU9rU1NPcjRPRnAwU0I1RGd0U3g4?oc=5" target="_blank">Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials</a>  <font color="#6f6f6f">The Lancet</font>

The safety and efficacy of gamma frequency auditory and visual stimulation in the treatment of alzheimer’s disease: a systematic review and meta-analysis
Naturegeneral

The safety and efficacy of gamma frequency auditory and visual stimulation in the treatment of alzheimer’s disease: a systematic review and meta-analysis

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9WQmt2UEQwQ1FITU81emVRY2tPOEtKTnhsWENEcVdzR1FUTmE2UUNYMEJkSFplNFQ1YUYwMXJGNVZlM0VDeTZiZ0tjWFJsWUJQNExHekFGa0czd0F1UlU0?oc=5" target="_blank">The safety and efficacy of gamma frequency auditory and visual stimulation in the treatment of alzheimer’s disease: a systematic review and meta-analysis</a>  <font color="#6f6f6f">Nature</font>

Efficacy and safety findings of the EXTRA study in older adult EGFR-mutant lung cancer patients receiving afatinib as first-line treatment | Scientific Reports
Natureworld

Efficacy and safety findings of the EXTRA study in older adult EGFR-mutant lung cancer patients receiving afatinib as first-line treatment | Scientific Reports

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1IUnlTUk5FRXNxLU91VGtRV3IwQktjcEFEbW4tNUxRNW1pSnhid1BIMF9uSlV4OHZBeFpJZ2ZqNW0yM05RVEY3aHhGMVpwVWUxNVdENVA4cG5YN2VzZEVR?oc=5" target="_blank">Efficacy and safety findings of the EXTRA study in older adult EGFR-mutant lung cancer patients receiving afatinib as first-line treatment | Scientific Reports</a>  <font color="#6f6f6f">Nature</font>

"Safety and efficacy of th" — Live Google News Trends & Headlines